Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Longevity Biotech
company
About
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $155K
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Founded in 2010 by President Mr. Scott Shandler, Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.04M
Longevity Biotech has raised a total of
$1.04M
in funding over 2 rounds. Their latest funding was raised on
Apr 2, 2015 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 2, 2015 | Grant | $885.50K | 1 |
National Science Foundation
|
— | Detail |
| Dec 11, 2013 | Grant | $155K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Longevity Biotech is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
